https://cytarabineinhibitor.co....m/rurh-bimetallene-n
Metabolic problem is defined by hyperlipidemia and cardio problems. We now have analyzed whether inhibition of glycosphingolipid synthesis can hinder metabolic syndrome in a male mouse style of type II diabetes (db/db). The db/db and control mice (C57/BL6) (n = 6) fed chow for 30 months got vehicle (5% Tween-80 in PBS; 100 μl), or a biopolymer-encapsulated D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (BPD) glycosphingolipid synthesis inhi
Like
Comment
Share
